VYNT Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 Dec 2023 @ 15:39):

Stats
Today's Volume	19 116.00
Average Volume	17 863.00
Market Cap	1.23M
EPS	$0 ( 2024-03-29 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0721
ATR14	$0.00900 (4.64%)

Insider Trading

Date	Person	Action	Amount	type
2021-11-09	Hansen Paul R.	Buy	6 783	Common Stock, $0.0001 par value
2023-01-17	Hansen Paul R.	Buy	4 032	Common Stock, $0.0001 par value
2023-01-17	Harris Geoffrey E.	Buy	5 712	Common Stock, $0.0001 par value
2023-01-17	Fletcher R John	Buy	4 368	Common Stock, $0.0001 par value
2023-01-17	Horobin Joanna	Buy	7 526	Common Stock, $0.0001 par value

INSIDER POWER
98.03
Last 98 transactions
Buy: 5 441 265 \| Sell: 193 337

Volume Correlation

Long: -0.14 (neutral)

Short: 0.17 (neutral)

Signal:(69.635) Neutral

Cancer Genetics Inc Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Cancer Genetics Inc Correlation - Currency/Commodity

0.09
( neutral )

0.11
( neutral )

0.00
( neutral )

0.20
( neutral )

0.08
( neutral )

-0.01
( neutral )

Cancer Genetics Inc Financials

Annual	2022
Revenue:	$666 000
Gross Profit:	$-342 000 (-51.35 %)
EPS:	$-3.87

FY	2022
Revenue:	$666 000
Gross Profit:	$-342 000 (-51.35 %)
EPS:	$-3.87

FY	2021
Revenue:	$1.15M
Gross Profit:	$-699 000 (-60.89 %)
EPS:	$-9.03

FY	2020
Revenue:	$867 000
Gross Profit:	$-234 000 (-26.99 %)
EPS:	$-1.492

Financial Reports:

No articles found.

Cancer Genetics Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Cancer Genetics Inc

Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency disorders (CDD,) and familial Parkinson's disease (PD). Vyant Bio, Inc. has a collaboration agreement to discover drugs for the treatment of Parkinson's Disease. The company is based in Cherry Hill, New Jersey.